Zhongguancun announced that its subsidiary Duoduo Pharmaceutical's application for a marketing license for calcium oxybenzenesulfonate capsules has been accepted by the State Drug Administration. The specification is 0.5g, and the acceptance number is CYHS2602461, marking that the marketing licensing process for this variety has entered the review stage.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.